Elevation Pharmaceuticals, Inc.: Series A $17M

Posted in I - Series A, Q - 3Q11, R - WEST, X - COPD, X - Respiratory, XX - CA

Elevation Pharmaceuticals (San Diego, CA) a clinical-stage biopharmaceutical company focused on aerosol therapies for respiratory disease and COPD, closed a $17M Series A financing. Participants include Canaan Partners, Care Capital, TPG Biotech and Mesa Verde Venture Partners.

Jul

2010

Agile Therapeutics, Inc.: Series B $45M

Posted in I - Series B, Q - 2Q10, R - NORTH EAST, X - Contraception, X - Drug:Device Combo, XX - NJ

Agile Therapeutics (Princeton, NJ) a clinical-stage pharmaceutical company focused on hormonal contraception, closed a $45M Series B financing. Participants include Investor Growth Capital, Care Capital, ProQuest Investments, Kaiser Permanente Ventures and Novitas Capital.

Jul

2010

Inotek Pharmaceuticals Corp.: Series D $18M

Posted in I - Series D, Q - 2Q10, R - NORTH EAST, X - Opthalmology, XX - MA

Inotek Pharmaceuticals (Lexington, MA) a clinical-stage small molecule company focused on age-related macular degeneration, glaucoma, cataract and diabetic retinopathy, closed a $18M Series D financing. Participants include Devon Park Bioventures, Rho Ventures, Care Capital, Pitango Venture Capital, MedImmune Ventures and Bio One Capital.

May

2010

NormOxys, Inc.: Series B $17.5M

Posted in I - Series B, Q - 2Q10, R - NORTH EAST, X - Cardiology, X - Hypoxia, X - Oncology, XX - MA

NormOxys (Wellesley, MA) a clinical-stage small molecule company focused on allosteric effectors of hemoglobin for heart failure and various cancers, closed a $17.5M Series B financing. Participants include Care Capital and Index Ventures.

Mar

2010

Vaxart, Inc.: Series B $12.5M

Posted in I - Series B, Q - 1Q10, R - WEST, X - Influenza, X - Toll Receptor, X - Vaccines, XX - CA

Vaxart (San Francisco, CA) a preclinical-stage developer of a platform vaccine technology focusing on oral delivery that leverages an adjuvant based upon a toll-like receptor, closed a $12.5M Series B financing. Participants include Care Capital.

Mar

2010

MicroCHIPS, Inc.: Series C $16.5M

Posted in I - Series C, Q - 1Q10, R - NORTH EAST, X - Device (Delivery), X - Device (Diabetes), X - Device (Osteoporosis), XX - MA

MicroCHIPS (Bedford, MA) a development-stage medical device company focused on implantable drug delivery and biosensing for diabetes and osteoporosis, closed a $16.5M Series C financing. Participants include InterWest Partners, Polaris Venture Partners, Novartis Venture Fund, Flybridge Capital Partners, Medtronic, Saints Capital, Intersouth Partners, Care Capital and CSK Venture Capital.

Feb

2010

Elevation Pharmaceuticals, Inc.: Series A $30M

Posted in I - Series A, Q - 1Q10, R - WEST, X - COPD, X - Respiratory, XX - CA

Elevation Pharmaceuticals (San Diego, CA) a preclinical-stage biopharmaceutical company focused on developing improved inhaled drug therapies for COPD , closed a $30M Series A financing. Participants include Canaan Partners, TPG Growth, Care Capital and Mesa Verde Venture Partners.

to top of page...